Literature DB >> 4012573

The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients.

J Jääskeläinen, M Haltia, E Laasonen, T Wahlström, S Valtonen.   

Abstract

The growth rate of intracranial meningiomas was studied in 43 patients against a histologic grading based on the degree of anaplasia. The mean time for doubling of the tumor volume was 415 days (138-1045) in grade I (benign), 178 days (34-551) in grade II (atypical), and 205 days (30-472) in grade III (anaplastic). The difference between grade I and the combined grades II-III was highly significant. Both the mitotic index and the absence of calcification on the computed tomography scan correlated strongly with the doubling time. The growth rate should be carefully considered in planning therapy and timing computed tomography studies for patients with meningioma.

Entities:  

Mesh:

Year:  1985        PMID: 4012573     DOI: 10.1016/0090-3019(85)90180-6

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  43 in total

Review 1.  Tumors of the meninges: proposed modifications of the World Health Organization classification.

Authors:  B W Scheithauer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.

Authors:  M Simon; J Boström; P Koch; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

3.  Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?

Authors:  Pedro Góes; Bruno Fernandes Oliveira Santos; Fernando Seiji Suzuki; Débora Salles; João Noberto Stávale; Sérgio Cavalheiro; Manoel Antônio de Paiva Neto
Journal:  J Neurooncol       Date:  2017-12-21       Impact factor: 4.130

4.  Therapeutic Role of Gamma Knife Stereotactic Radiosurgery in Neuro-Oncology.

Authors:  Rupen Desai; Keith M Rich
Journal:  Mo Med       Date:  2020 Jan-Feb

5.  Imaging and diagnostic advances for intracranial meningiomas.

Authors:  Raymond Y Huang; Wenya Linda Bi; Brent Griffith; Timothy J Kaufmann; Christian la Fougère; Nils Ole Schmidt; Jöerg C Tonn; Michael A Vogelbaum; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Ian F Dunn
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

Review 6.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Paediatric meningeal tumours.

Authors:  C L Mallucci; S E Parkes; P Barber; J Powell; M C Stevens; A R Walsh; A D Hockley
Journal:  Childs Nerv Syst       Date:  1996-10       Impact factor: 1.475

8.  Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression.

Authors:  Hong-Lin Ke; Rong-Hu Ke; Shi-Ting Li; Bin Li; Hai-Tao Lu; Xiao-Qiang Wang
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

9.  Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation.

Authors:  V A Nagar; J R Ye; W H Ng; Y H Chan; F Hui; C K Lee; C C T Lim
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

10.  Cell kinetics of the malignant evolution of meningothelial meningioma.

Authors:  T Iwaki; I Takeshita; M Fukui; K Kitamura
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.